You have no items in your shopping cart.
Description
Research Area
Images & Validation
−| Application Notes |
|---|
Key Properties
−| Expression System | HEK293 |
|---|---|
| Target | SOST |
| Reactivity | Human |
| Tag | N-6×His |
| Expression Region | Gln 24 - Tyr 213 |
| Endotoxins | 1.0 EU per μg |
| Conjugation | Unconjugated |
| MW | 22.3 kDa |
| Purity | 90% |
Storage & Handling
−| Storage | -20°C |
|---|---|
| Form/Appearance | Powder |
| Buffer/Preservatives | PBS, pH 7.4 |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Similar Products
−Recombinant Human SOST Protein, N-His-SUMO [orb2963266]
ELISA, SDS-PAGE, WB
>90% as determined by SDS-PAGE.
34.04 kDa
1 mg, 50 μg, 100 μgRecombinant Human SOST Protein, C-His [orb2967392]
ELISA, SDS-PAGE, WB
>90% as determined by SDS-PAGE.
23.85 kDa
1 mg, 50 μg, 100 μgRecombinant Human SOST Protein, C-His [orb2834922]
>90% as determined by SDS-PAGE.
24.03 kDa
20 μg, 50 μg, 100 μgRecombinant Human SOST Protein, N-His-SUMO [orb2832517]
>90% as determined by SDS-PAGE.
34.04 kDa
20 μg, 50 μg, 100 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Quick Database Links
UniProt Details
−NCBI Reference Sequences
−| RefSeq | AAI01087.1 |
|---|
Protocol Information
Wu, Y. et al. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling Eur Rev Med Pharmacol Sci, 21, 470-478 (2017)

